BeStock  

Supernus Pharmaceuticals SUPN

US equityMarket cap rank #1870Drug Manufacturers - Specialty & Generic
$28.61 +$0.26 (+0.92%)
Market closed · Nov 21, 9:10 am ET · Last extended-hours $28.00 -2.13%
Open$28.39
Prev close$28.35
Day range$28.15 – $29.51
Volume2.83M
Market cap$5.94B
P/E (TTM)–
Dividend yield–

Fundamentals

Latest reported quarter: Q3, ended Sep 2026

Revenue$226.77M+18.0% YoY
Operating profit$22.72M+137.7% YoY
Net profit$20.91M+146.4% YoY
Diluted EPS$0.35+143.8% YoY
Free cash flow$6.38M+110.3% YoY
Operating cash flow$6.61M

Revenue, last 8 quarters

$174.2MDec '24$149.8MMar '25$165.5MJun '25$192.1MSep '25$211.6MDec '25$207.7MMar '26$219.1MJun '26$226.8MSep '26

Net profit, last 8 quarters

$15.3MDec '24$-11.8MMar '25$22.5MJun '25$-45.1MSep '25$-4.1MDec '25$-2.3MMar '26$-58.4MJun '26$20.9MSep '26

Diluted EPS by quarter

0.27Dec '24-0.21Mar '250.40Jun '25-0.80Sep '25-0.07Dec '25-0.04Mar '26-1.01Jun '260.35Sep '26

Free cash flow by quarter

$44.2MDec '24$30.3MMar '25$58.1MJun '25$-61.8MSep '25$19.4MDec '25$66.5MMar '26$-5.4MJun '26$6.4MSep '26

Annual revenue

$520.4MFY20$579.8MFY21$667.2MFY22$607.5MFY23$661.8MFY24$719.0MFY25

Profitability & balance sheet

Gross margin87.6%
Operating margin3.2%
Net margin-5.1%
Return on equity-4.2%
Return on assets-3.1%
Return on invested capital-4.3%
Current ratio2.49
Liabilities / assets24.0%
Cash & investments$359.46M
Total debt$28.58M
Net cash (debt)$330.88M
Free cash flow / sales10.1%

Income statement

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Revenue as Reported $226.77M $219.06M $207.71M $718.95M $211.57M
Total Operating Revenue $226.77M $219.06M $207.71M $718.95M $211.57M
Cost of Revenue $27.02M $33.67M $23.39M $74.56M $23.01M
Gross Profit $199.75M $185.39M $184.31M $644.39M $188.57M
Operating Expense $177.03M $188.43M $190.26M $681.25M $174.74M
Selling and Admin Expenses $128.06M $133.64M $125.17M $485.56M $122.39M
-Selling & Marketing Expense $90.51M $92.79M $86.98M $288.65M $83.19M
-General & Admin Expense $37.54M $40.85M $38.20M $196.91M $39.21M
Research & Development $25.76M $29.46M $39.44M $106.24M $27.83M
Depreciation & Amortization & Depletion $23.22M $25.33M $25.64M $89.46M $24.53M
-Depreciation & Amortization $23.22M $25.33M $25.64M $89.46M $24.53M
Operating Profit $22.72M -$3.04M -$5.94M -$36.86M $13.82M
Net Non-Operating Interest Income (Expense) $1.53M $315,000.00 $2.38M $13.25M $2.02M
Non-Operating Interest Income $2.25M $2.63M $2.38M $13.25M $2.02M
Non-Operating Interest Expense $718,000.00 $2.32M – $0.00 $0.00
Other Income (Expense) -$1.54M -$54.92M -$2.39M -$25.42M -$17.76M
Special Income (Charges) -$1.54M -$54.92M -$2.39M -$25.42M -$17.76M
-Less:Restructuring and Mergern & Acquisition $0.00 $0.00 $2.39M $25.42M $17.76M
-Less:Impairment of Capital Assets $1.54M $54.92M – $0.00 –
Pretax Profit $22.71M -$57.65M -$5.95M -$49.03M -$1.91M
Tax $1.80M $723,000.00 -$3.66M -$10.48M $2.19M
Net Profit $20.91M -$58.37M -$2.29M -$38.55M -$4.11M
Profit from Continuing Operations $20.91M -$58.37M -$2.29M -$38.55M -$4.11M
Net Income to Parent Company $20.91M -$58.37M -$2.29M -$38.55M -$4.11M
Net Income to Common Stockholders $20.91M -$58.37M -$2.29M -$38.55M -$4.11M
Basic EPS $0.36 -$1.01 -$0.04 -$0.68 -$0.07
Diluted EPS $0.35 -$1.01 -$0.04 -$0.68 -$0.07

Balance sheet

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Assets $1.40B $1.43B $1.50B $1.45B $1.45B
Total Current Assets $711.22M $723.50M $731.58M $644.18M $644.18M
Cash and Cash Equivalents & Short-Term Investments $359.46M $372.07M $384.24M $308.67M $308.67M
-Cash and Cash Equivalents $175.88M $179.95M $184.87M $128.45M $128.45M
-Short Term Investments $183.58M $192.11M $199.37M $180.22M $180.22M
Receivables $214.71M $211.66M $182.18M $187.80M $187.80M
-Accounts Receivable $214.71M $211.66M $182.18M $187.80M $187.80M
Inventory $87.11M $83.92M $87.06M $82.39M $82.39M
Other Current Assets $49.93M $55.85M $78.09M $65.33M $65.33M
Total Non-Current Assets $686.48M $704.61M $769.15M $808.47M $808.47M
Net PPE $10.02M $10.20M $10.04M $10.53M $10.53M
-Gross PPE $29.59M $29.36M $28.80M $28.80M $28.80M
-Accumulated Depreciation -$19.57M -$19.17M -$18.75M -$18.26M -$18.26M
Goodwill and Other Intangible Assets $565.67M $588.89M $670.38M $694.34M $694.34M
-Goodwill $119.43M $119.43M $120.67M $124.88M $124.88M
-Other Intangible Assets $446.24M $469.46M $549.71M $569.46M $569.46M
Non-Current Deferred Assets $54.32M $49.06M $30.82M $38.35M $38.35M
Other Non-Current Assets $56.47M $56.47M $57.90M $65.25M $65.25M
Total Liabilities $335.21M $396.88M $423.92M $390.93M $390.93M
Total Current Liabilities $285.40M $347.38M $373.93M $338.17M $338.17M
Payables $8.52M $5.59M $10.17M $2.68M $2.68M
-Accounts Payable $8.52M $5.59M $10.17M $2.68M $2.68M
Current Accrued Expenses $230.75M $266.61M $245.95M $226.16M $226.16M
Short-Term Debt and Capital Lease Obligation $7.62M $10.74M $10.64M $10.61M $10.61M
-Current Capital Lease Obligation $7.62M $10.74M $10.64M $10.61M $10.61M
Other Current Liabilities $10.91M $40.08M $82.97M $69.27M $69.27M
Total Non-Current Liabilities $49.82M $49.51M $49.99M $52.76M $52.76M
Long Term Debt and Capital Lease Obligation $28.58M $29.43M $30.27M $30.37M $30.37M
-Long Term Capital Lease Obligation $28.58M $29.43M $30.27M $30.37M $30.37M
Other Non-Current Liabilities $21.24M $20.08M $19.72M $22.40M $22.40M
Total Equity $1.06B $1.03B $1.08B $1.06B $1.06B
Stockholders' Equity $1.06B $1.03B $1.08B $1.06B $1.06B
Capital Stock $58,000.00 $58,000.00 $58,000.00 $57,000.00 $57,000.00
-Common Stock $58,000.00 $58,000.00 $58,000.00 $57,000.00 $57,000.00
Additional Paid-In Capital $584.58M $574.09M $561.42M $543.83M $543.83M
Retained Earnings $478.13M $457.21M $515.58M $517.88M $517.88M
Gains/Losses Not Affecting Retained Earnings -$280,000.00 -$138,000.00 -$255,000.00 -$44,000.00 -$44,000.00
Non-Current Deferred Liabilities – – – $0.00 $0.00

Cash flow

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Operating Cash Flow $6.61M -$4.81M $66.52M $47.33M $19.86M
Net cash flow from continuing operations $6.61M -$4.81M $66.52M $47.33M $19.86M
Net Income from Continuing Operations $20.91M -$58.37M -$2.29M -$38.55M -$4.11M
Depreciation & Depletion & Amortization $23.63M $25.75M $26.13M $91.56M $25.02M
Deferred Tax -$5.30M -$16.95M $5.92M $5.21M $19.00M
Other Non-Cash Items -$3.33M -$19.72M $4.93M $30.38M $20.02M
Change in Working Capital -$44.61M -$2.79M $21.75M -$75.16M -$51.36M
-Change in Receivables -$3.06M -$29.47M $5.62M -$22.30M -$16.42M
-Change in Inventory -$10.53M -$306,000.00 -$105,000.00 -$7.50M -$4.18M
-Change in Prepaid Assets $6.26M $21.66M -$12.43M -$13.18M -$6.91M
-Change in Payables and Accrued Expense -$37.28M $5.33M $28.67M -$32.17M -$23.85M
Net cash flow from investing $7.72M $7.09M -$19.22M $4.11M -$51.31M
Net Cash Flow from Continuing Investing Activities $7.72M $7.09M -$19.22M $4.11M -$51.31M
Net PPE Purchase and Sale -$230,000.00 -$568,000.00 $0.00 -$1.34M -$427,000.00
Net Investment Purchase and Sale $7.95M $7.66M -$19.22M $298.54M -$50.88M
Financing Cash Flow -$18.40M -$7.20M $9.12M $9.13M $8.53M
Net Cash Flow from Continuing Financing Activities -$18.40M -$7.20M $9.12M $9.13M $8.53M
Net Common Stock Issuance $2.34M $4.12M $13.67M $37.62M $8.56M
Net Other Financing Charges -$20.73M -$11.32M -$4.56M -$28.49M -$31,000.00
Ending Cash Balance $177.33M $181.40M $186.32M $129.90M $129.90M
Net Change in Cash -$4.07M -$4.92M $56.42M $60.57M -$22.92M
Beginning Cash Balance $181.40M $186.32M $129.90M $69.33M $152.82M
Free Cash Flow $6.38M -$5.38M $66.52M $45.99M $19.43M
Gain/Loss from Continuing Operations – $0.00 -$21,000.00 $439,000.00 –
Net Business Purchase and Sale – – – -$293.09M $0.00
Net Issuance Payments Of Debt – – – $0.00 –

Discussion

No comments yet — be the first to weigh in on SUPN.

Sign in to join the discussion.

Scroll to Top